ADRIATIC: A phase III trial of durvalumab 6 tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

S. Senan, N. Shire, G. Mak, W. Yao, H. Jiang

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)25-25
JournalAnnals of Oncology
Publication statusPublished - Apr 2019

Cite this